# Nitrous Oxide for Major Depressive Disorder

> **NCT03932825** · PHASE2 · COMPLETED · sponsor: **Lingjiang Li** · enrollment: 44 (actual)

## Conditions studied

- Depressive Disorder
- Major Depressive Disorder
- Treatment Resistant Depression
- Depressive Disorder, Major
- Depression

## Interventions

- **DRUG:** Nitrous Oxide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03932825
- **Lead sponsor:** Lingjiang Li
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-03-31
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2021-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03932825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03932825, "Nitrous Oxide for Major Depressive Disorder". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT03932825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*